J. Goldman & Co’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7M | Sell |
656,564
-202,567
| -24% | -$4.84M | 0.38% | 68 |
|
|
2025
Q1 | $21.3M | Buy |
859,131
+731,988
| +576% | +$18.2M | 0.53% | 37 |
|
|
2024
Q4 | $2.4M | Buy |
+127,143
| New | +$2.4M | 0.06% | 197 |
|
|
2023
Q3 | – | Sell |
-51,931
| Closed | -$2.08M | – | 329 |
|
|
2023
Q2 | $2.08M | Buy |
+51,931
| New | +$2.08M | 0.08% | 132 |
|
|
2020
Q1 | – | Sell |
-40,325
| Closed | -$1.83M | – | 243 |
|
|
2019
Q4 | $1.83M | Buy |
+40,325
| New | +$1.83M | 0.13% | 99 |
|
|
2019
Q3 | – | Sell |
-90,418
| Closed | -$3.93M | – | 227 |
|
|
2019
Q2 | $3.93M | Buy |
+90,418
| New | +$3.93M | 0.27% | 69 |
|
|
2018
Q3 | – | Sell |
-35,895
| Closed | -$1.15M | – | 236 |
|
|
2018
Q2 | $1.15M | Buy |
+35,895
| New | +$1.15M | 0.06% | 153 |
|
|
2017
Q4 | – | Sell |
-203,400
| Closed | -$7.64M | – | 294 |
|
|
2017
Q3 | $7.64M | Buy |
+203,400
| New | +$7.64M | 0.39% | 46 |
|